[{"orgOrder":0,"company":"Antistress AG - Burgerstein Vitamine","sponsor":"Antistress AG - Burgerstein Vitamine","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"SWITZERLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2017","type":"Inapplicable","leadProduct":"Ferrous Fumarate","moa":"Transferrin receptor protein 1; Egl nine homolog 1; Histone deacetylase 8; Alpha-hemoglobin-stabilizing protein; Hemoglobin subunit alpha; Frataxin, mitochondrial; Ferritin heavy chain; Flap endonuclease 1; Endonuclease 8-like 1; Endonuclease 8-like 2; DNA polymerase beta; Ceruloplasmin; Serotransferrin","graph1":"Hematology","graph2":"Undisclosed","graph3":"Antistress AG - Burgerstein Vitamine","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine","highestDevelopmentStatusID":"1","companyTruncated":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine"},{"orgOrder":0,"company":"Antistress AG - Burgerstein Vitamine","sponsor":"Antistress AG - Burgerstein Vitamine","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2018","type":"Inapplicable","leadProduct":"Ferrous Fumarate","moa":"Transferrin receptor protein 1; Egl nine homolog 1; Histone deacetylase 8; Alpha-hemoglobin-stabilizing protein; Hemoglobin subunit alpha; Frataxin, mitochondrial; Ferritin heavy chain; Flap endonuclease 1; Endonuclease 8-like 1; Endonuclease 8-like 2; DNA polymerase beta; Ceruloplasmin; Serotransferrin","graph1":"Hematology","graph2":"Undisclosed","graph3":"Antistress AG - Burgerstein Vitamine","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine","highestDevelopmentStatusID":"1","companyTruncated":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine"},{"orgOrder":0,"company":"Antistress AG - Burgerstein Vitamine","sponsor":"Antistress AG - Burgerstein Vitamine","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Ferrous Fumarate","moa":"Transferrin receptor protein 1; Egl nine homolog 1; Histone deacetylase 8; Alpha-hemoglobin-stabilizing protein; Hemoglobin subunit alpha; Frataxin, mitochondrial; Ferritin heavy chain; Flap endonuclease 1; Endonuclease 8-like 1; Endonuclease 8-like 2; DNA polymerase beta; Ceruloplasmin; Serotransferrin","graph1":"Hematology","graph2":"Undisclosed","graph3":"Antistress AG - Burgerstein Vitamine","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine","highestDevelopmentStatusID":"1","companyTruncated":"Antistress AG - Burgerstein Vitamine \/ Antistress AG - Burgerstein Vitamine"}]

Find Clinical Drug Pipeline Developments & Deals by Antistress AG - Burgerstein Vitamine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          June 24, 2019

                          Lead Product(s) : Ferrous Fumarate

                          Therapeutic Area : Hematology

                          Highest Development Status : Undisclosed

                          Recipient : Isabelle Herter-Aeberli

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          December 03, 2018

                          Lead Product(s) : Ferrous Fumarate

                          Therapeutic Area : Hematology

                          Highest Development Status : Undisclosed

                          Recipient : Isabelle Herter-Aeberli

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          OTS 2025
                          Not Confirmed
                          OTS 2025
                          Not Confirmed

                          Details : Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Iron Deficiencies.

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          October 30, 2017

                          Lead Product(s) : Ferrous Fumarate

                          Therapeutic Area : Hematology

                          Highest Development Status : Undisclosed

                          Recipient : Swiss Federal Institute of Technology

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank